Effect of immunosuppression on the incidence of lymphoma formation
- 1 June 1992
- journal article
- Published by Wiley in Clinical Transplantation
- Vol. 6 (3pt2) , 220-222
- https://doi.org/10.1111/j.1399-0012.1992.tb00624.x
Abstract
Since 1969, a high incidence of lymphomas has been reported to be associated with transplantation. This phenomenon has been markedly amplified during the eighties. This article analyzes some of the most contributive references on the topic. The major risk factors are duration of immunosuppression, dosage of immunosuppressive reagents and, most importantly, the number of immunosuppressive agents used either together or sequentially.This publication has 6 references indexed in Scilit:
- Post-Transplantation Lymphoproliferative Disorder and OKT3New England Journal of Medicine, 1991
- Increased Incidence of Lymphoproliferative Disorder after Immunosuppression with the Monoclonal Antibody OKT3 in Cardiac-Transplant RecipientsNew England Journal of Medicine, 1990
- INCREASED FREQUENCY OF POSTTRANSPLANT LYMPHOMAS IN PATIENTS TREATED WITH CYCLOSPORINE, AZATHIOPRINE, AND PREDNISONETransplantation, 1989
- CYCLOSPORIN IN CADAVERIC RENAL TRANSPLANTATION: ONE-YEAR FOLLOW-UP OF A MULTICENTRE TRIALThe Lancet, 1983
- A Randomized Clinical Trial of Cyclosporine in Cadaveric Renal TransplantationNew England Journal of Medicine, 1983
- CYCLOSPORIN A INITIALLY AS THE ONLY IMMUNOSUPPRESSANT IN 34 RECIPIENTS OF CADAVERIC ORGANS: 32 KIDNEYS, 2 PANCREASES, AND 2 LIVERSThe Lancet, 1979